Wednesday, July 29, 2020
Kodak Stock Up More Than 1,000% On Deal To Produce Generic Drug Ingredients
Here is the article.
Some analysts are questioning the move, wondering why the deal wouldn't have been given to a company already involved in the pharmaceutical industry. President Trump may have held a preference for a producer outside of the current drug regime. Political tensions have increased this week, as pharma executives and analysts react to Trump's recent executive orders that aimed to lower drug prices.
Whatever the reasoning, it's a fascinating chance for Kodak to make a new start, and investors have reacted bullishly. So far this week, the stock is up around 1,150%. The company came out of bankruptcy in 2013 and has struggled to grow over the last five years. Moving into a field like drug sales could provide a good avenue for the photography pioneer.